Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) Between December 2014 and March 2021, 144
patients with aortic (Ao) or mitral (Mi) paravalvular
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) in
patients with massive PE. Study aim: We aimed to share the results of
thrombolytic treatment in
patients) needs mortality risk assessment also on the outhospital level to stratify the mortality risk of
patients) in angiography in
patients with coronary heart disease (CHD) and chronic kidney disease (CKD) was shown, however
and Methods - The study included 624
patients (1199 eyes) with POAG aged 45 to 93 years. The control group
Patients with malignant tumors face an elevated risk of cerebrovascular complications
deformity disorder is more severe in
patients with CHF of III-IV functional classes [Mondillo S. et al, 2011].
CARDIOVASCULAR CHARACTERISTICS OF PATIENTS WITH HEMORRHAGIC FEVER WITH RENAL SYNDROMEMukhetdinova, G.A.,
Fazlyeva, R.M.,
Ibragimova, L.A.,
Mirsaeva, G.K.,
Tutelyan, A.V.,
Stepanov, O.G.,
Khasanova, G.M.,
Мухетдинова, Г.А.,
Фазлыева, Р.М.,
Ибрагимова, Л.А.,
Мирсаева, Г.Х. (2018) Objective: to evaluate cardiovascular characteristics of
patients with hemorrhagic fever with renal